Hologic has announced a strategic push into AI-powered, portable diagnostic imaging, joining peers in a market projected to reach $70.92 billion by 2032. The launch of the CMS ACCESS Model in July 2026, which will incentivize outcome-based care, is expected to accelerate adoption of software-defined imaging at the bedside. Hologic’s latest mobile ultrasound and low-field MRI systems incorporate proprietary machine-learning algorithms that deliver hospital-grade image quality, reducing per-scan facility overhead by up to 30%. In recent pilot studies across ten U.S. community clinics, Hologic’s platform demonstrated a 25% reduction in time to diagnosis and a 15% improvement in lesion detection rates compared with standard portable ultrasound units.

In a bid to combat rising rates of underscreened women, Hologic has rolled out Ultimate Defense, a nationwide awareness initiative encouraging routine Pap and HPV testing. The campaign will partner with over 1,200 primary-care and OB/GYN practices across 40 states, aiming to increase screening compliance by 20% within 18 months. Hologic will provide participating clinics with educational toolkits, co-branded patient reminders and discounted test reagents, targeting an estimated 3 million women who have missed screening in the past three years. Early internal projections suggest this program could help detect an additional 8,500 pre-cancerous lesions annually, preventing an estimated 1,100 cases of invasive cervical cancer over the next decade.